Form SC 13D/A Valeant Pharmaceuticals Filed by: Pershing Square Capital Management, L.P.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. VZ
9. SPY
10. LMT

Go back to Form SC 13D/A Valeant Pharmaceuticals Filed by: Pershing Square Capital Management, L.P.

Valeant Pharma (VRX) Enters Information Sharing Agreement with Pershing Square

March 23, 2016 4:37 PM EDT

Pershing Square filed an amended 13D on Valeant Pharma (NYSE: VRX) today. The following letter was disclosed:

Dear Mr. Pearson:

I am delighted to join the Valeant Pharmaceuticals International, Inc. (Valeant) board, and I look forward to making a contribution to the company.

This letter, intended solely for the benefit of Valeant, contains a series of undertakings by myself, my firm and the investment funds that we advise (collectively, Pershing Square or we). The undertakings in the following two paragraphs of this letter will be effective so long as the confidential... More